Comerica Bank’s Akero Therapeutics AKRO Stock Holding History

Comerica Bank’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-56	Closed	-$2.66K	–	3716
2025 Q3	$2.66K	Sell	56 -32	-36%	-$1.55K	﹤0.01%	3493
2025 Q2	$4.7K	Sell	88 -77	-47%	-$3.5K	﹤0.01%	3375
2025 Q1	$6.68K	Buy	165 +86	+109%	+$3.65K	﹤0.01%	3269
2024 Q4	$2.19K	Buy	+79	New	+$2.39K	﹤0.01%	3473
2023 Q4	–	Sell	-236	Closed	-$11.9K	–	3731
2023 Q3	$11.9K	Buy	+236	New	+$11K	﹤0.01%	3158

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank's AKRO Position: Q4 2025 in Review

Comerica Bank sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 56 shares — an estimated $2.66K sold.

Comerica Bank first reported a position in AKRO in Q3 2023 and held it in 5 quarters. The position peaked at $11.9K in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Comerica Bank reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Comerica Bank sold 56 Akero Therapeutics shares in Q4 2025, an estimated $2.66K.
Comerica Bank first reported a position in Akero Therapeutics in Q3 2023 and held it in 5 quarters.
Comerica Bank's Akero Therapeutics position peaked at $11.9K in Q3 2023.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.